Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (141-150 of 181) with videos related to

Pageof 19
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2016
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear MedicineGiorgio Treglia, Cumali Aktolun, Arturo Chiti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2011
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsFrancesco Giammarile, Lisa Bodei, Carlo Chiesa, et al.
Oncology|November 17, 2021
Variations in Radioiodine Therapy in Europe: Decision-Making after Total ThyroidectomyFlavio Forrer, Galina Farina Fischer, Ole Maas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 29, 2009
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytomaMarkus Luster, Wolfram Karges, Katrin Zeich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2017
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the DetailsGlenn D Flux, Frederik A Verburg, Carlo Chiesa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 9, 2019
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphyLuca Giovanella, Anca M Avram, Ioannis Iakovou, et al.
Photodiagnosis and Photodynamic Therapy|November 10, 2019
Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitroLennart Ocker, Anna Adamus, Laura Hempfling, et al.
European Thyroid Journal|July 10, 2023
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practiceJaume Capdevila, Desiree' Deandreis, Cosimo Durante, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2022
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidenceMaximilian J Reinecke, Gerrit Ahlers, Andreas Burchert, et al.
Thyroid : Official Journal of the American Thyroid Association|May 23, 2013
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statementFrederik A Verburg, Markus Luster, Cristina Cupini, et al.
Pageof 19

Showing results (141-150 of 181) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2016
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear MedicineGiorgio Treglia, Cumali Aktolun, Arturo Chiti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 16, 2011
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsFrancesco Giammarile, Lisa Bodei, Carlo Chiesa, et al.
Oncology|November 17, 2021
Variations in Radioiodine Therapy in Europe: Decision-Making after Total ThyroidectomyFlavio Forrer, Galina Farina Fischer, Ole Maas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 29, 2009
Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytomaMarkus Luster, Wolfram Karges, Katrin Zeich, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 11, 2017
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy: The Devil Is in the DetailsGlenn D Flux, Frederik A Verburg, Carlo Chiesa, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 9, 2019
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphyLuca Giovanella, Anca M Avram, Ioannis Iakovou, et al.
Photodiagnosis and Photodynamic Therapy|November 10, 2019
Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitroLennart Ocker, Anna Adamus, Laura Hempfling, et al.
European Thyroid Journal|July 10, 2023
Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practiceJaume Capdevila, Desiree' Deandreis, Cosimo Durante, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2022
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidenceMaximilian J Reinecke, Gerrit Ahlers, Andreas Burchert, et al.
Thyroid : Official Journal of the American Thyroid Association|May 23, 2013
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statementFrederik A Verburg, Markus Luster, Cristina Cupini, et al.
Pageof 19